FSFG vs REGN · P/E 9.3, rev $5.3M vs P/E 14, rev $14.34B
First Savings Financial Group Inc (FSFG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
First Savings Financial Group Inc (FSFG) is a banks - regional company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FSFG revenue for 2024-09-30 was $5.3M. Net income was $3.7M. Revenue was down 6.1% from 2023-09-30 to 2024-09-30. FSFG currently screens at market cap $180.2M and trailing P/E 9.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FSFG currently screens at market cap $180.2M and trailing P/E 9.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FSFG and REGN stock pages for the full models.
Not investment advice.